CliffBio
small molecule

ENDOMETRIN

PROGESTERONE

Loss of exclusivity—loss of exclusivity
CompanyFerring Pharmaceuticals →See this company's full patent-cliff portfolio

Drug detail

Brand nameENDOMETRIN
Active ingredientPROGESTERONE
Strength100MG
Dosage formINSERT
RouteVAGINAL
ModalitySmall molecule
FDA approvalJune 2007
Marketing statusRX

More from Ferring Pharmaceuticals

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

ENDOMETRIN patent cliff — loss of exclusivity — | CliffBio